Veritone Files DEF 14A
Veritone Inc files DEF 14A with SEC, a preliminary proxy statement.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Corvus Pharmaceuticals Sets November 5 Date for Q3 2026 Results and Business Update
Corvus Pharmaceuticals says it will provide a business update and third-quarter 2026 financial results on November 5, 2026.
M impact | EQUITY | Oct 29, 2026, 12:16 PM UTC
Insperity Q3 Gross Profit $207 Million
Insperity reported gross profit of $207 million for the third quarter.
M impact | EQUITY | Oct 29, 2026, 12:13 PM UTC
TUK Group to Acquire Toronto Site for 30-Unit Rental Development
TUK Group plans to acquire a Bayview Avenue site off the Bridle Path for a 30-unit rental development, expanding its Toronto footprint.
M impact | EQUITY | Oct 29, 2026, 12:04 PM UTC
Quanome Receives US$13.5 Million Prepayment for AI Inference Services
The customer service prepayment is the first cash milestone payment under a 60-month enterprise order and supports procurement and build-out.
M impact | EQUITY | Oct 29, 2026, 12:04 PM UTC
Akebia Therapeutics to Report Third-Quarter 2026 Results
Akebia Therapeutics says it will report third-quarter 2026 financial results and discuss recent business highlights.
M impact | EQUITY | Oct 29, 2026, 12:03 PM UTC
Insperity Announces Third-Quarter Results
Insperity announced its third-quarter results.
M impact | EQUITY | Oct 29, 2026, 12:03 PM UTC